Shalini Sharp, CFO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 4,000 shares at $54.72 ($216K) on 2015-02-18, disclosed to the SEC on 2015-02-20.
Scheduled sale ($216k) by CFO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.93 | 3,704 | $200K | 92.5% |
| 2 | $54.72 | 296 | $16K | 7.5% |
| Total | $53.99 avg | 4,000 | $216K | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |